In vitro osteogenic potential of human bone marrow stromal cells cultivated in porous scaffolds from mineralized collagen.

Porous 3D structures from mineralized collagen were fabricated applying a procedure in which collagen fibril reassembly and precipitation of nanocrystalline hydroxyapatite (HA) occur simultaneously. The resulting matrices were evaluated in vitro with respect to their suitability as scaffolds for bone tissue engineering. We found a high capacity of the material to bind serum proteins as well as to absorb Ca2+ ions, which could be advantageous to promote cell attachment, growth, and differentiation. Human bone marrow stromal cells (hBMSCs) were seeded onto the 3D scaffolds and cultivated for 4 weeks in the presence and absence of osteogenic supplements. We studied viability, proliferation, and osteogenic differentiation in terms of total lactate dehydrogenase (LDH) activity, DNA content, and alkaline phosphatase (ALP) activity. Furthermore, the expression for bone-related genes (ALP, bone sialo protein II (BSP II), and osteocalcin) was analyzed. In our investigation we found a 2.5-fold to 5-fold raise in DNA content and an increase of ALP activity for osteogenic induced hBMSC on collagen HA scaffolds. The expression of ALP and BSP II in these cells was also stimulated in the course of cultivation; however, we did not detect an upregulation of osteocalcin gene expression. These data suggest, that porous collagen HA scaffolds are suitable for the expansion and osteogenic differentiation of hBMSC and are therefore promising candidates for application as bone grafts.

[1]  M. Gelinsky,et al.  Porous three-dimensional scaffolds made of mineralised collagen: Preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone , 2008 .

[2]  M. Gelinsky,et al.  Biphasic, but monolithic scaffolds for the therapy of osteochondral defects , 2007 .

[3]  Peter X Ma,et al.  Suppression of apoptosis by enhanced protein adsorption on polymer/hydroxyapatite composite scaffolds. , 2007, Biomaterials.

[4]  M. Gelinsky,et al.  In vitro ossification and remodeling of mineralized collagen I scaffolds. , 2006, Tissue engineering.

[5]  J T Czernuszka,et al.  Collagen-hydroxyapatite composites for hard tissue repair. , 2006, European cells & materials.

[6]  W. Grayson,et al.  Effects of hydroxyapatite in 3-D chitosan-gelatin polymer network on human mesenchymal stem cell construct development. , 2006, Biomaterials.

[7]  A. Jada,et al.  Physico-chemical characteristics and protein adsorption potential of hydroxyapatite particles: influence on in vitro biocompatibility of ceramics after sintering. , 2006, Colloids and surfaces. B, Biointerfaces.

[8]  Atsuro Yokoyama,et al.  Biomimetic porous scaffolds with high elasticity made from mineralized collagen--an animal study. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[9]  Vehid Salih,et al.  Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. , 2005, Biomaterials.

[10]  C. Rey,et al.  Ion exchanges in apatites for biomedical application , 2005, Journal of materials science. Materials in medicine.

[11]  J. Ong,et al.  Protein adsorption and osteoblast precursor cell attachment to hydroxyapatite of different crystallinities. , 2005, The International journal of oral & maxillofacial implants.

[12]  S. Both,et al.  Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells , 2004, Journal of materials science. Materials in medicine.

[13]  P. Kasten,et al.  Evaluation of Mineralized Collagen and α-Tricalcium Phosphate as Scaffolds for Tissue Engineering of Bone Using Human Mesenchymal Stem Cells , 2004, Cells Tissues Organs.

[14]  T. Kusunose,et al.  Hydroxyapatite particles as a controlled release carrier of protein. , 2004, Biomaterials.

[15]  Lingrong Liu,et al.  Preparation and Characterization of Collagen–Hydroxyapatite Composite Used for Bone Tissue Engineering Scaffold , 2003, Artificial cells, blood substitutes, and immobilization biotechnology.

[16]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[17]  S. Bellis,et al.  Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. , 2001, Journal of biomedical materials research.

[18]  P. Ramires,et al.  The influence of titania/hydroxyapatite composite coatings on in vitro osteoblasts behaviour. , 2001, Biomaterials.

[19]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[20]  Michael Mertig,et al.  Biomimetic mineralization of collagen by combined fibril assembly and calcium phosphate formation , 1999 .

[21]  J. Rieu,et al.  Interaction of a plasma-sprayed hydroxyapatite coating in contact with human osteoblasts and culture medium. , 1999, Journal of biomedical materials research.

[22]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[23]  P Zioupos,et al.  Mechanical properties and the hierarchical structure of bone. , 1998, Medical engineering & physics.

[24]  O. Fromigué,et al.  Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. , 1997, Cytokine.

[25]  J. Gustafsson,et al.  Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. , 1997, DNA and cell biology.

[26]  R. Midura,et al.  Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[28]  Su‐Li Cheng,et al.  Expression of bone matrix proteins during dexamethasone‐induced mineralization of human bone marrow stromal cells , 1996, Journal of cellular biochemistry.

[29]  G. Stein,et al.  Influence of dexamethasone on the vitamin D–mediated regulation of osteocalcin gene expression , 1991, Journal of cellular biochemistry.

[30]  M. Owen.  Marrow stromal stem cells , 1988, Journal of Cell Science.

[31]  Anja Lode,et al.  Mineralised collagen—an artificial, extracellular bone matrix—improves osteogenic differentiation of bone marrow stromal cells , 2008, Journal of materials science. Materials in medicine.

[32]  A. Barbero,et al.  Real‐time quantitative RT‐PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro , 2002, Journal of cellular biochemistry.

[33]  D. Benayahu,et al.  Differential gene expression of cultured human osteoblasts , 2001, Journal of cellular biochemistry.

[34]  N Passuti,et al.  Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic. , 1999, Journal of biomedical materials research.

[35]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.